Project description
Remote monitoring to bring down the cost of clinical trials
The cost of conducting clinical trials is already high and rising each year. With the cost of a single big trial reaching into the hundreds of millions of euros, pharmaceutical and biotech companies are selective about the drug development and research they conduct. This, in turn, impacts public health and the availability of new treatments. There are approaches to reduce the cost of large-scale clinical trials. The EU-funded Citrus project will focus on reducing the cost of on-site monitoring, which currently accounts for up to 14 % of overall clinical study costs. Specifically, it proposes the wider use of mobile technologies, centrally available data to evaluate site performance, electronic data capture and other efficiency-improving options – an end-to-end solution that offers remote monitoring capabilities.
Objective
Clinical trial costs have been constantly on the rise in the last years the total cost of a single big trial can reach €600 million. The increasing costs have significant implications for public health, as it affects pharmaceutical and biotech companies’ willingness to undertake clinical trials, which in turn limits patient access to novel treatments. To monitor clinical trials, it is a common practice to conduct site visits frequently and to verify source data during these visits. On-Site monitoring accounts for up to 14% of overall clinical study costs.
These costs can be reduced by making wider use of mobile technologies, centrally available data to evaluate site performance, electronic data capture, and other efficiency-improving options.
Existing systems on the market do not offer solutions to the problem. There are systems for clinical trial financial management; systems for electronic data capture; systems that provide access to electronic health records (EHR) and lab results (e-source) or access to mobile health devices. All these separate systems do not necessarily talk to each other, staff at clinical research sites report usage of three different systems to enter patient/study data.
Citrus - Clinical Trial Management & Remote Monitoring is the first revolutionary solution to offer remote monitoring capabilities. It is an end-to-end solution which includes CTMS, direct access to lab results and EHR, access to mHealth devices and it ensures data privacy compliance when data is accessed remotely.
Founded in 2008, CRU Hungary leads the clinical research services in Center-East Europe. Their 4 clinical research sites are preferred companies such as Pfizer, AstraZeneca and GSK. Our IT department have been developing solutions that answer to real pains in the clinical trial process and whose purchase is currently negotiated with T-Mobile and leading university hospitals in Hungary. We expect a 5-year ROI of 9.49.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- natural sciences computer and information sciences software
- medical and health sciences health sciences public health
- natural sciences computer and information sciences computer security data protection
- medical and health sciences basic medicine pharmacology and pharmacy pharmaceutical drugs
- social sciences law
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs
MAIN PROGRAMME
See all projects funded under this programme -
H2020-EU.3. - PRIORITY 'Societal challenges
See all projects funded under this programme -
H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
SME-1 - SME instrument phase 1
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) H2020-EIC-SMEInst-2018-2020
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
2131 GOD
Hungary
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.